A. K. Tektas Et Al. , "Effects of Lipoprotein-Associated Phospholipase A2 on Arginase/Nitric Oxide Pathway in Hemodialysis Patients," RENAL FAILURE , vol.34, no.6, pp.738-743, 2012
Tektas, A. K. Et Al. 2012. Effects of Lipoprotein-Associated Phospholipase A2 on Arginase/Nitric Oxide Pathway in Hemodialysis Patients. RENAL FAILURE , vol.34, no.6 , 738-743.
Tektas, A. K., USLU, S., YALÇIN, A. U., ŞAHİN, G., Temiz, G., KARA, M., ... TEMEL, H. E.(2012). Effects of Lipoprotein-Associated Phospholipase A2 on Arginase/Nitric Oxide Pathway in Hemodialysis Patients. RENAL FAILURE , vol.34, no.6, 738-743.
Tektas, Aysegul Et Al. "Effects of Lipoprotein-Associated Phospholipase A2 on Arginase/Nitric Oxide Pathway in Hemodialysis Patients," RENAL FAILURE , vol.34, no.6, 738-743, 2012
Tektas, Aysegul K. Et Al. "Effects of Lipoprotein-Associated Phospholipase A2 on Arginase/Nitric Oxide Pathway in Hemodialysis Patients." RENAL FAILURE , vol.34, no.6, pp.738-743, 2012
Tektas, A. K. Et Al. (2012) . "Effects of Lipoprotein-Associated Phospholipase A2 on Arginase/Nitric Oxide Pathway in Hemodialysis Patients." RENAL FAILURE , vol.34, no.6, pp.738-743.
@article{article, author={Aysegul Korkmaz Tektas Et Al. }, title={Effects of Lipoprotein-Associated Phospholipase A2 on Arginase/Nitric Oxide Pathway in Hemodialysis Patients}, journal={RENAL FAILURE}, year=2012, pages={738-743} }